share_log
Reuters ·  May 3 07:19
Ascendis Pharma A/S : Wells Fargo Raises Target Price to $262 From $260
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment